To include your compound in the COVID-19 Resource Center, submit it here.

FDA advisory committee votes against expanded indication for Pacira's Exparel

Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) said FDA’s Anesthetic and Analgesic Drug Products Advisory Committee voted 6-4 against approval of a resubmitted sNDA for

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE